Catalyst Wire Dossier Catalyst Wire Dossier

Parnaparin sodium extended-release formulation

Parnaparin sodium · Cosmo Technologies Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Parnaparin sodium extended-release formulation, covering 2009-03-25 to 2009-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Tolerability of a New Oral Extended-Release Formulation Containing Parnaparin Sodium, Administered Add-on Therapy [Phase 2]

See pricing